NOVARTIS PHARMACEUTICALS UK LIMITED
The company operates as the British subsidiary of the publicly traded Swiss multinational Novartis AG, focusing on the manufacture, clinical research, and supply of pharmaceutical products to the UK healthcare system.
Get an alert when NOVARTIS PHARMACEUTICALS UK LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
—
Latest balance sheet
Net assets
£178m
+23.2% highest in 3 filed years
Employees
1,634
+22.9% highest in 3 filed years
Profit before tax
£73m
+58.9% highest in 3 filed years
Net assets
3-year trend · vs Health Care median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | £630,898,000 | £743,034,000 | £770,424,000 | +3.7% | |
| Operating profit | £36,931,000 | £47,419,000 | £73,505,000 | +55% | |
| Profit before tax | £34,152,000 | £45,831,000 | £72,842,000 | +58.9% | |
| Net profit | £23,968,000 | £36,198,000 | £69,631,000 | +92.4% | |
| Cash | — | — | — | — | |
| Total assets less current liabilities | £154,634,000 | £165,857,000 | £190,389,000 | +14.8% | |
| Net assets | £131,569,000 | £144,450,000 | £177,905,000 | +23.2% | |
| Equity | £131,569,000 | £144,450,000 | £177,905,000 | +23.2% | |
| Average employees | 848 | 1,330 | 1,634 | +22.9% | |
| Wages | £99,936,000 | £110,670,000 | £131,100,000 | +18.5% | |
| Directors' remuneration | £2,244,000 | £1,713,000 | £2,686,000 | +56.8% | |
| Directors' pension contributions | £67,000 | £80,000 | £102,000 | +27.5% | |
| Highest paid director | £932,228 | £1,023,657 | £1,802,283 | +76.1% |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Operating margin | 5.9% | 6.4% | 9.5% | |
| Net margin | 3.8% | 4.9% | 9.0% | |
| Return on capital employed | 23.9% | 28.6% | 38.6% | |
| Gearing (liabilities / total assets) | 65.1% | 65.0% | 60.6% | |
| Current ratio | 1.15x | 1.41x | 1.48x | |
| Interest cover | 12.82x | 29.86x | 50.24x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 2 times since incorporation
- NOVARTIS PHARMACEUTICALS UK LIMITED 1997-03-03 → present
- SANDOZ PHARMACEUTICALS (UK) LIMITED 1992-01-01 → 1997-03-03
- SANDOZ PRODUCTS LIMITED 1911-12-08 → 1992-01-01
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Abridged
- Yes — abridged accounts (limited disclosure)
- Auditor
- KPMG LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The directors have considered the financial position of the company as at the balance sheet date, including the net assets of £177,905,000 and net current assets of £125,581,000. The company also has a broad customer base, and a strong history of profitable operations. There are no indications that this will not continue to be the case through the foreseeable future.”
Significant events
- “The agreement to transfer the residual activities of Gyroscope Therapeutics Limited to Novartis Pharmaceuticals UK Limited was signed on 17 June 2025.”
- “Other receivables include Nil (2024: £39,944,000) relating to VPAS-2019 End of Scheme reconciliation which was received from Department of Health and Social Care in March 2025.”
- “The intangible assets include software and development costs towards implementation of new ERP system which was transferred to Novartis Pharma AG during the year.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 61 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| CULLEN, Richard Samuel | Secretary | 2026-01-01 | — | — |
| GUPTA, Sandeep | Director | 2025-05-12 | Jun 1982 | Indian |
| KAHLSTROEM, Johan Mikael Olof | Director | 2024-11-01 | Jul 1980 | Swedish |
Show 61 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| ALLSUP, Valerie | Secretary | 1997-06-05 | 2000-03-01 |
| CULLEN, Richard Samuel | Secretary | 2021-01-01 | 2022-07-20 |
| HOLGATE, Benjamin James Michael | Secretary | 2011-06-22 | 2016-01-31 |
| JENNINGS, Sally Jane | Secretary | 2000-12-31 | 2008-03-11 |
| ROBERTS, Helen | Secretary | 2008-03-11 | 2011-06-22 |
| ROBINSON, Timothy William | Secretary | 2022-07-20 | 2026-01-01 |
| SHORTHOSE, Sally Jane | Secretary | 2000-03-01 | 2000-12-31 |
| THIRKETTLE, Paul Richard Edward | Secretary | — | 1997-06-05 |
| WESTON, Rebecca Ann | Secretary | 2016-02-01 | 2021-01-01 |
| ADAMS, Adrian | Director | 1999-04-30 | 2001-06-08 |
| AHMAD, Haseeb | Director | 2017-03-28 | 2021-04-01 |
| ARROCHA, Edgar Humberto | Director | 2014-08-26 | 2016-08-15 |
| ASHTON, David Thomas | Director | 2001-01-23 | 2001-09-27 |
| BARLOCHER, Urs, Dr | Director | 1993-05-20 | 1995-10-01 |
| BATZER, Martin Christopher, Dr | Director | 1995-10-01 | 1997-02-13 |
| BHATT, Chinmay Umesh | Director | 2020-09-01 | 2022-05-31 |
| BRANDLI, Reto Ernst | Director | 2000-01-28 | 2006-03-01 |
| BRAZIER, Richard John | Director | 2006-02-22 | 2009-07-01 |
| BREU, Raymund, Dr | Director | 2000-12-11 | 2010-03-31 |
| BROOKS, Jason Mark | Director | 2019-05-09 | 2025-04-08 |
| CHARHON, Jean-Jacques | Director | 2006-03-01 | 2007-05-15 |
| CORNUT, Eric, Dr | Director | 2007-02-01 | 2013-01-24 |
| CUMMINS, Gordon John | Director | 2004-05-20 | 2006-02-01 |
| FAHEY, Michael John | Director | 2001-11-30 | 2004-05-20 |
| FULLAGAR, Edgar | Director | 1997-04-07 | 2002-04-23 |
| FULLAGAR, Edgar | Director | — | 1994-07-01 |
| GABRIEL, Silvio | Director | 2001-02-01 | 2005-03-16 |
| GAMACHE, Marie-Andree Renee | Director | 2022-06-29 | 2024-10-31 |
| GUERARD, Frederic Marcel Benoit | Director | 2012-09-06 | 2015-03-31 |
| GUIDI, Guido Angelo Giovanni | Director | 2013-01-24 | 2017-01-18 |
| HANTSON, Ludwig Norbert Michel, Dr | Director | 2005-03-21 | 2007-02-01 |
| JOSE, Teresa | Director | 2009-07-01 | 2012-04-03 |
| KAPADIA, Sandipkumar Shantilal | Director | 2012-04-03 | 2014-08-26 |
| KINDLER, Hans | Director | 1997-04-24 | 2000-12-11 |
| KIRSCH, Harry Werner | Director | 2013-06-20 | 2018-07-10 |
| KREISSIG, Roland | Director | 2021-12-14 | 2022-05-31 |
| KROPS, Eduard Gerhard | Director | 1993-05-01 | 1993-08-26 |
| LACAZE, Oriane Fanny | Director | 2016-08-15 | 2019-05-09 |
| LINK, Max | Director | — | 1993-08-26 |
| METCALFE, Richard | Director | 1993-02-01 | 1997-12-31 |
| O'DOWD, Hugh Michael | Director | 2015-03-31 | 2016-09-16 |
| PALACHI, Barak Avraham | Director | 2017-05-14 | 2018-03-19 |
| PARIS, William Drummond | Director | 2001-09-14 | 2005-04-22 |
| PRAT, Lluis | Director | 2007-05-22 | 2016-03-10 |
| RACLOZ, Jacques | Director | 1994-07-01 | 1997-10-31 |
| RANG, Humphrey Peter, Professor | Director | 1992-06-01 | 1997-04-07 |
| REINHARDT, Joerg | Director | 1999-01-26 | 2005-03-21 |
| SAXENA, Subhanu | Director | 2005-04-22 | 2009-08-26 |
| SCHEIFFELE, Anna Mari, Dr | Director | 2018-05-09 | 2021-10-31 |
| SCHILLINGER, Erwin, Dr | Director | 1992-09-01 | 1993-05-01 |
| SCHLIENGER, Peter | Director | 1992-09-01 | 1995-10-01 |
| SNOOK, Christopher David | Director | 2016-03-10 | 2017-05-31 |
| SOIRON, Rolf | Director | — | 1993-05-20 |
| STROPPEL, Stefan Hans | Director | 1998-01-19 | 2001-01-23 |
| SYMON, John | Director | 1997-11-06 | 1999-08-31 |
| SYMONDS, Jonathan Richard | Director | 2010-03-31 | 2013-06-20 |
| TSCHUDIN, Marie-France | Director | 2017-01-18 | 2019-05-22 |
| VASELLA, Daniel | Director | 1995-10-01 | 1997-02-13 |
| WACK, Rene | Director | — | 1992-12-31 |
| WEBB, Susan Ann | Director | 2009-08-26 | 2012-09-06 |
| YOUMANS, James Clifford | Director | 1997-04-24 | 1997-06-04 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Novartis Uk Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 252 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-08-27 | AA | accounts | Accounts with accounts type full | |
| 2026-04-02 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2026-01-05 | AP03 | officers | Appoint person secretary company with name date | |
| 2026-01-05 | TM02 | officers | Termination secretary company with name termination date | |
| 2025-10-03 | AA | accounts | Accounts with accounts type full | |
| 2025-05-13 | AP01 | officers | Appoint person director company with name date | |
| 2025-04-17 | TM01 | officers | Termination director company with name termination date | |
| 2025-04-02 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-01-14 | CH01 | officers | Change person director company with change date | |
| 2024-11-05 | AP01 | officers | Appoint person director company with name date | |
| 2024-11-04 | TM01 | officers | Termination director company with name termination date | |
| 2024-08-06 | AA | accounts | Accounts with accounts type full | |
| 2024-04-03 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-10-12 | AA | accounts | Accounts with accounts type full | |
| 2023-09-01 | CH01 | officers | Change person director company with change date | |
| 2023-04-04 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-09-26 | AA | accounts | Accounts with accounts type full | |
| 2022-08-16 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2022-07-26 | AP03 | officers | Appoint person secretary company with name date | |
| 2022-07-25 | TM02 | officers | Termination secretary company with name termination date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 5
- Capital events
- 0
- Officers appointed
- 1
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.